|
|
|
|
||
Re: Corcept’s response to 214 petition - here are the new dates Per filing with USPTO of Jan 6, the new "deadlines" that have been mutually agreed to are as follows: Patent Owner Corcept Therapeutics, Inc. and Petitioner Teva Pharmaceuticals USA, Inc. hereby jointly stipulate as follows: 1. Move Due Date 1 from February 13, 2020 to February 27, 2020; 2. Move Due Date 2 from May 7, 2020 to June 4, 2020; 3. Move Due Date 3 from June 18, 2020 to July 16, 2020. All other dates in the Board’s November 20, 2019 Scheduling Order (Paper 20) will remain the same. This paper is being filed with approval from counsel for Petitioners. Date: January 6, 2020 F. Dominic Cerrito (Reg. No. 38,100) |
return to message board, top of board |